Understanding Cancer Diagnosis and Treatment During Pregnancy
This study is gathering information about pregnant women who are diagnosed with cancer. Researchers want to understand how different cancer treatments, or delays in treatment, affect both the mother's health and the health of her baby. They are looking at how children develop over time, specifically their developmental quotient (a measure of a child's development compared to others their age). You may be able to join if you are a pregnant woman diagnosed with cancer within 6 weeks before your last period or up to 6 months after your pregnancy ends. This is an observational study, meaning researchers will collect information without giving specific interventions, and they plan to include about 400 participants. The study aims to learn more about the best ways to care for mothers and babies in these situations.
- Study design
- This is an observational study that aims to enroll about 400 women. Researchers will collect information about their diagnosis, treatment, and outcomes.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Children's developmental quotient will be measured yearly from 3 months up to 12 years of age. Some children in this study have been followed for up to 28 years.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Maternal Cancer Diagnosis and Treatment During Pregnancy:a Database for Maternal, Fetal, and Neonatal Outcomes
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Elyce H Cardonick, MD · PRINCIPAL_INVESTIGATOR · Cooper Health System
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Neonatal Developmental QuotientYearly from 3 months to 12 years of age
Pediatrician asked to assess developmental age compared to chronological age, ie developmental quotient